Drug
Khk7791
Khk7791: highest development phase Phase 3, developed by Kyowa Kirin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KHK7791 NCT04767581 | Phase 3 | Hyperphosphatemia |
| KHK7791 NCT03864445 | Phase 2 | Hyperphosphatemia |
Latest
No recent events.
Follow Khk7791 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.